Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers
Journal of Clinical Oncology · 20.09.2024 · 42 (27) · 3170-3176
DOI: 10.1200/jco.24.00868 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.09.2024. Verfasst von Emily L Zeme und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology , to patients seen in their own clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
- Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA.
ORCID-Profile: Katherine Van Loon, Robin K Kelley, John D Gordan
Zitieren
APA
Zeme, E. L., Van Loon, K., Kelley, R. K., & Gordan, J. D. (2024). Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers. Journal of Clinical Oncology, 42(27), 3170-3176. https://doi.org/10.1200/jco.24.00868
Vancouver
Zeme EL, Van Loon K, Kelley RK, Gordan JD. Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers. Journal of Clinical Oncology. 2024;42(27):3170-3176. doi:10.1200/jco.24.00868
BibTeX
@article{Zeme2024,
author = {Zeme, Emily L and Van Loon, Katherine and Kelley, Robin K and Gordan, John D},
title = {Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ ERBB2 -Altered Advanced Biliary Tract Cancers},
journal = {Journal of Clinical Oncology},
year = {2024},
volume = {42},
number = {27},
pages = {3170--3176},
doi = {10.1200/jco.24.00868}
}
EUVIMED